Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/30/2025

Amantadine Dosing and Safety Guidelines

Elderly Patients

  • The Centers for Disease Control and Prevention recommends that the daily dose of amantadine must not exceed 100 mg for either prophylaxis or treatment in patients aged 65 years or older due to age-related decline in renal function and dose-dependent toxicity 1, 2, 3
  • Renal function declines with increasing age, leading to drug accumulation, and some elderly patients require doses below 100 mg/day, particularly elderly women who have smaller average body size and higher risk of side effects 2, 3, 4
  • Close observation for CNS toxicity is essential, especially during the first week 4, 5

Renal Impairment

  • The Centers for Disease Control and Prevention recommends dose reduction for patients with creatinine clearance <50 mL/min/1.73m² because amantadine is excreted unchanged in the urine 1, 2, 3
  • Patients should be observed carefully for adverse reactions after dose adjustment 1, 3
  • Hemodialysis contributes minimally to amantadine clearance 1, 2

Pediatric Dosing

  • The Centers for Disease Control and Prevention recommends that for children aged 1-9 years, the prescribed dose should be 5 mg/kg/day (not to exceed 150 mg/day) to reduce toxicity risk 1, 2
  • For children aged >10 years, the approved dose is 200 mg/day (100 mg twice daily) 1, 2
  • For children weighing <40 kg regardless of age, the prescribed dose should be 5 mg/kg/day 1, 2

Safety Considerations

  • The Centers for Disease Control and Prevention warns that plasma amantadine concentrations >3000 ng/mL are associated with severe toxicity, including myoclonus, hallucinations, and delirium 6
  • Common side effects include nervousness, anxiety, insomnia, difficulty concentrating, and lightheadedness, which occur in approximately 13% of patients versus 4% with placebo 4
  • Serious CNS toxicity, including marked behavioral changes, delirium, hallucinations, agitation, and seizures, can occur, particularly in high-risk populations 4, 5

High-Risk Populations

  • Patients with seizure disorders, psychiatric disorders, renal insufficiency, and elderly patients, especially women, require dose reduction and close monitoring 4, 5

Management Algorithm

  • Verify renal function before initiating therapy in any elderly patient 4
  • Start at a maximum of 100 mg/day in elderly patients 4
  • Consider further reduction below 100 mg/day for elderly women, those with any renal impairment, or those with seizure/psychiatric history 4
  • Monitor closely for CNS toxicity, especially during the first week 4, 5
  • Reduce dose or discontinue immediately if serious side effects emerge 4, 5

Common Pitfalls to Avoid

  • Failing to adjust dose for renal function in elderly patients significantly increases the risk of adverse effects 4, 5
  • Using standard 200 mg/day dosing in patients ≥65 years instead of the required maximum 100 mg/day 1, 2, 3
  • Not monitoring for drug resistance when using amantadine for influenza treatment, as resistant viruses can emerge during therapy 6